Established in 1987, Kempex stands as an respected international trading company, specialising in pharmaceutical raw materials and additives tailored for the animal feed industry. With a strategic focus on sourcing high-quality supplies, Kempex procures a substantial portion of its inventory from regions outside Europe, serving clientele primarily across Europe and the Middle East. Following an investment by MKB Fonds, Kempex embarked on a dynamic buy-and-build strategy aimed at enhancing its market presence and offerings. This strategic endeavor reached a significant milestone in September 2014 with the acquisition of the veterinary activities of Tocelo Pharma. Under the brand name Tocelo Vet, Kempex continued and expanded upon these activities, solidifying its position as a leading player in the veterinary pharmaceutical sector.